Merck & Co Inc (MRK)

MRK (NYSE:Drugs)
$59.75
pos +0.41
+0.69%
Today's Range: 59.35 - 59.77 | MRK Avg Daily Volume: 10,836,700
Last Update: 11/26/14 - 4:00 PM EST
Volume: 6,280,616
YTD Performance: 18.56%
Open: $59.70
Previous Close: $59.34
52 Week Range: $47.61 - $61.33
Oustanding Shares: 2,850,873,371
Market Cap: 168,914,247,232
6-Month Chart
TheStreet Ratings Grade for MRK
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 6 6 6 6
Moderate Buy 0 0 0 0
Hold 6 6 7 6
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 2.00 2.00 2.08 2.00
Latest Dividend: 0.44
Latest Dividend Yield: 2.97%
Dividend Ex-Date: 09/11/14
Price Earnings Ratio: 32.20
Price Earnings Comparisons:
MRK Sector Avg. S&P 500
32.20 32.40 26.00
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
-0.65% 19.49% 78.95%
GROWTH 12 Mo 3 Yr CAGR
Revenue -6.80 -0.04 -0.01
Net Income -28.30 3.60 0.65
EPS -26.70 4.32 0.74
Earnings for MRK:
EBITDA 14.65B
Revenue 44.03B
Average Earnings Estimates
Qtr (12/14) Qtr (03/15) FY (12/14) FY (12/15)
Average Estimate $0.86 $0.78 $3.49 $3.58
Number of Analysts 8 1 12 12
High Estimate $0.88 $0.78 $3.51 $3.75
Low Estimate $0.83 $0.78 $3.46 $3.26
Prior Year $0.88 $0.88 $3.49 $3.49
Growth Rate (Year over Year) -1.99% -11.36% 0.02% 2.58%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
By

David Katz

 | Nov 21, 2014 | 9:30 AM EST

Its prospects exploded with a breakthrough drug.

bullishMerck estimates, target increased at Morgan Stanley

Nov 18, 2014 | 7:22 AM EST

MRK estimates were raised through 2017, Morgan Stanley said. Company can deliver higher Vytorin/Zetia sales. Equal-weight rating and new $64 price target. 

By

Jim Cramer

 | Nov 17, 2014 | 4:16 PM EST

The U.S. markets and economy are unique.

By

Jim Cramer

 | Nov 10, 2014 | 1:35 PM EST

Beat the short-term crown in these three areas for the long term.

By

Doug Kass

 | Oct 27, 2014 | 7:51 AM EDT
Where it began.
By

Chris Versace and Lenore Hawkins

 | Oct 26, 2014 | 8:00 PM EDT

Market action could get a bumpy after last week's big move.

By

Christopher Versace

 | Oct 25, 2014 | 12:00 PM EDT

Americans are living much longer these days -- and there are a number of ways to invest.

By

Gary Berman

 | Oct 16, 2014 | 12:03 PM EDT

Look to be a small buyer now that shares triggered a long-term oversold signal.

By

Jim Cramer

 | Oct 14, 2014 | 5:58 AM EDT

Buying this dip may be harder than you think.

By

Jim Cramer

 | Oct 9, 2014 | 4:08 PM EDT

Stop picking on PepsiCo, Allergan and Apple.

Lights, Camera, ACTION! This move lately in GPRO has been stellar, up nearly 12% over the...
For just under two weeks MCD has been bumping up against a very solid wall of resista...
Texas Instruments is surging today. Shares are up over 2.7% and are moving further i...
Shares of Amazon (AMZN) have been trading within a set of Fibonacci retracements measured ...

REAL MONEY PRO'S BEST IDEAS

Columnist Tweets

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.